Search clinical trials for: Tacrolimus and MMF

Total 270703 results

University Hospital, Limoges

Not yet recruiting

Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY) (EASY)

Liver Transplantation | Immunosuppression

France
Novartis Pharmaceuticals

Completed

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients (CIRRUS I)

Kidney Transplant Rejection

United States, Hungary, Japan, United Kingdom, Belgium, Spain, Netherlands, Germany, Australia, France, Korea, Republic of, Switzerland, Norway, Italy, Latvia, Sweden, Argentina, Brazil, Canada, Czechia
National Institute of Allergy and Infectious Diseases...
National Heart, Lung, and Blood Institute (NHLBI); Genentech, Inc.; Rho Federal... and other collaborators

Terminated

Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation

Cardiac Allograft Vasculopathy | Heart Transplant Recipients

United States
University Hospital Freiburg
Roche Pharma AG; Genzyme, a Sanofi Company; Astellas Pharma GmbH

Completed

Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation (Harmony)

Disorder Related to Renal Transplantation

Germany
Northwestern University
Novartis

Completed

Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens

End Stage Renal Failure With Renal Transplant

United States
Centre Hospitalier Intercommunal Creteil

Completed

Enjoyment of Infant Formulas Based on Cow or Goat Milk Protein (CHARLIE)

Feeding Behavior | Feeding, Bottle

France
University of Minnesota
Wyeth is now a wholly owned subsidiary of Pfizer; Roche Pharma AG; Genzyme, a...

Completed

Calcineurin Inhibitor Sparing After Kidney Transplantation (CNI-Sparing)

CNI Side Effects

United States
University Hospital, Limoges

Terminated

Bayesian Dose Adjustment of Immunosuppressants After Lung Transplantation (BASALT)

Lung and Heart-lung Transplantation

Belgium, France
Colorado Blood Cancer Institute

Unknown

Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor

Lymphoma | Multiple Myeloma | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia

United States
Novartis Pharmaceuticals

Completed

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension (CONTRAIL I)

Liver Transplant Rejection

United States, Belgium, Germany, Spain, Argentina, Netherlands, Italy, Hungary, France, Czechia
Kasr El Aini Hospital

Completed

Efficiency of Fractional-Laser Resurfacing Followed by Topical Tacrolimus 0.03% Cream vs Tacrolimus Alone in Vitiligo

Stable Vitiligo
Novartis Pharmaceuticals

Completed

Efficacy, Safety, Tolerability, Pharmacokinetics of Sotrastaurin-tacrolimus vs. Mycophenolic Acid-tacrolimus in de Novo Liver Transplant Patients

Liver Transplantation

Belgium, Germany, Italy, United States, Switzerland, Spain, Austria, Czechia, France, Argentina, Finland, Canada
Fondo Nacional de Desarrollo Científico y Tecnológico...

Completed

Steroid Withdrawal in Pediatric Renal Transplant: Impact on Growth, Bone Metabolism and Acute Rejection

Kidney Diseases

Chile
Astellas Pharma Inc
Astellas Pharma Taiwan, Inc.

Completed

A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients

Kidney Transplantation | Transplantation Immunology | Host vs Graft Reaction

Taiwan
Astellas Pharma Inc
Astellas Pharma Taiwan, Inc.

Completed

A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.

Liver Transplantation | Transplantation Immunology | Host vs Graft Reaction

Taiwan
University of Miami
Wyeth-Ayesrst Pharmaceuticals, Roche Laboratories, and Fujusawa Healthcare...

Completed

Tacrolimus/Sirolimus Versus Tacrolimus/Mycophenolate Mofetil (MMF) Versus Neoral/Sirolimus in Adult, Primary Kidney Transplantation

Adult Primary Kidney Transplantation

United States
Peking University People's Hospital

Unknown

Natural Killer Cells Reconstitution Kinetics Post Haploidentical Transplantation

Natural Killer Cell Mediated Immunity

China
National Institute of Allergy and Infectious Diseases...
Clinical Trials in Organ Transplantation

Terminated

Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation

Kidney Transplant Recipients

United States, Canada
Colorado Blood Cancer Institute

Unknown

Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression

Graft Versus Host Disease

United States
Assiut University

Unknown

The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized Vitiligo

Vitiligo Vulgaris
Astellas Pharma Inc

Completed

Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys (TIGRE)

KIDNEY TRANSPLANTATION

Italy
University of Luebeck
Astellas Pharma GmbH

Completed

Minimizing Immunosuppression in Old for Old Kidney Transplantation (ESP-CNI)

Kidney Transplantation

Germany
AO Clinical Investigation and Publishing Documentation

Recruiting

Focused Registry to Collect Clinical Data on the MatrixWAVE System (FRMatrixWAVE)

Mandibular Fractures

Germany, United States
Shahid Beheshti University of Medical Sciences

Unknown

Immunosuppression After Repeat Keratoplasty

Keratopathy

Iran, Islamic Republic of
University of Southern California
National Cancer Institute (NCI)

Withdrawn

Holographic Mm-Wave Imaging in Patients Undergoing Radiation Therapy

Unspecified Adult Solid Tumor

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating of Calcineurin Inhibitors Versus Sirolimus in Renal Allograft Recipient

Kidney Transplantation

Taiwan
Nanjing University School of Medicine

Completed

Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V)

Lupus Nephritis

China
Astellas Pharma Inc

Completed

Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney Transplantation (TWIST)

Kidney Transplantation

Belgium, Italy, Taiwan, France, South Africa, Turkey, Germany, United Kingdom, Hungary, Czech Republic, Romania, Sweden, Poland, Israel
Astellas Pharma Global Development, Inc.
Kyowa Kirin Co., Ltd.

Completed

Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients

Kidney Transplantation | Primary Focal Segmental Glomerulosclerosis (FSGS)

United States, Canada
Sidney Kimmel Comprehensive Cancer Center at Johns...

Completed

Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide

Leukemia | Multiple Myeloma | Hodgkin's Lymphoma | Non Hodgkin's Lymphoma | Myelodysplastic Syndrome(MDS)

United States
ITB-Med LLC

Recruiting

A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation

Kidney Transplantation

Spain, Sweden, Austria
Astellas Pharma Inc

Completed

Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis

Keratoconjunctivitis | Conjunctivitis

Japan
Hannover Medical School

Completed

MMF After Pediatric Liver Transplantation

Liver Transplantation | Chronic Kidney Disease

Germany
Southern Medical University, China
First Affiliated Hospital, Sun Yat-Sen University; Nanfang Hospital of Southern...

Not yet recruiting

Sirolimus-based Immunosuppression Treatment Regimen for Liver Transplantation

Liver Transplantation

China
ITB-Med LLC

Completed

A Dose Escalation Study in de Novo Renal Transplantation

Kidney Transplantation

United States
Novartis Pharmaceuticals

Completed

Extension Study to Evaluate the Long-term Efficacy and Safety of Everolimus in Liver Transplant Recipients

Liver Transplant Recipient

Belgium, Spain, Germany, Italy, Australia, United States, Netherlands, Ireland, Sweden, Brazil, Colombia, France, Russian Federation, Argentina, Czechia, United Kingdom
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients (RAD)

Liver Transplantation

United States, Belgium, Colombia, Spain, Germany, Italy, Australia, Israel, France, Hungary, Netherlands, Argentina, Canada, Ireland, Sweden, Brazil, United Kingdom, Russian Federation, Czech Republic
Oslo University Hospital

Active, not recruiting

Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects (MicrobioTac)

Kidney Transplant; Complications | Immune Suppression

Norway
Novartis Pharmaceuticals

Completed

CCFZ533X2201 - PoC Study in de Novo Renal Transplantation

Kidney Transplantation

United States, Netherlands, Germany, Brazil
Astellas Pharma Inc
Astellas Pharma Korea, Inc.

Completed

Pharmacokinetics of Tacrolimus in Liver Transplantation Patients Treated With Prograf and Modified Release Tacrolimus

Liver Transplantation

Korea, Republic of
AZ-VUB

Unknown

Long-term Function of Beta Cell Allografts in Non-uremic Type 1 Diabetic Patients

Diabetes Mellitus, Type 1

Belgium
Nanfang Hospital of Southern Medical University

Recruiting

ATG in HLA-matched Sibling HSCT as GVHD Prophylaxis

Hematopoietic Stem Cell Transplantation

China
NYU Langone Health
Bristol-Myers Squibb

Recruiting

Belatacept in De Novo Heart Transplantation

Heart Transplantation

United States
Zhi-Hong Liu, M.D.
The First Affiliated Hospital with Nanjing Medical University; China Medical... and other collaborators

Completed

Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis

Lupus Nephritis

China
Heleen Grootjans
Chiesi Farmaceutici S.p.A.

Recruiting

Trial Comparing Immediate Versus Extended Release Tacrolimus; Reducing Calcineurin Inhibitor Related Toxicity in Lung Transplantation Patients (REVOLUTION)

Lung Transplant; Complications

Netherlands
Stanford University

Completed

Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation

B-cell Lymphoma | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Myeloproliferative Disorder | T-cell Lymphoma

United States
University of Sao Paulo General Hospital

Completed

MPA Pharmacokinetics in Renal Transplantation

Kidney Transplantation Recipients

Brazil
Fuzhou General Hospital

Unknown

Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy

Kidney Transplant | Chronic Allograft Nephropathy

China
Limerick BioPharma

Completed

Safety and Tolerability of LIM-0705 in Healthy Male Subjects (LIM)

Healthy

Australia
The Methodist Hospital Research Institute
Veloxis Pharmaceuticals

Withdrawn

Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant

Acute Rejection of Renal Transplant | Kidney Disease, End-Stage | Donor Specific Antibodies

Search clinical trials for: Tacrolimus and MMF

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations